|
|
||||||||

* Division of Gastrointestinal Pathology, Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322; and
Department of Pathology, University of Chicago, Chicago, IL 60637
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The TJ undergoes dynamic physiological changes when stimulated by various mediators, such as cytokines (8, 9) and microbial toxins (10, 11). Multiple second messenger pathways have been found to modulate permeability characteristics of developing and mature junctions by modification of various junctional proteins phosphorylation state and/or linkage to the actin cytoskeleton (9, 12, 13, 14, 15). Furthermore, actin-myosin interactions, promoted by phosphorylation of the 20-kDa regulatory myosin L chain (MLC), control the contractility of actomyosin in nonmuscle cells (16). Agents that stimulate contraction of the actomyosin ring cause a decrease in barrier function (enhanced paracellular permeability), while relaxation results in enhanced barrier function (decreased paracellular permeability) (17).
In previous work, our laboratory has shown that high-density PMN migration across model epithelial monolayers in vitro results in the disruption of epithelial permeability (18, 19, 20) and the production of multifocal wounds in the epithelia that are able to reseal following removal of PMN (18, 21). Alternatively, in vitro studies using Madin-Darby canine kidney (22) or T84 cells (18), a model human intestinal epithelial cell line, demonstrate that barrier function is preserved during low-density PMN transepithelial migration, suggesting that the opening of the intercellular junctions is a rapid and reversible process. Indeed, passage of migrating immune cells across vascular endothelium or epithelial monolayers, during a normal immune response or immune surveillance, is generally believed to be a rapid process that does not damage the integrity of the monolayer. Therefore, transcellular migration requires mechanisms that open intercellular junctions to allow passage of circulating cells while, at the same time, maintaining barrier function. However, the mechanisms that govern this process remain undefined.
In this study, using a physiologically relevant model of PMN transepithelial migration in which PMN migrate in the basolateral to apical direction, we have characterized PMN-induced alterations in T84 monolayers that occur in a step-wise fashion during PMN migration. This is the first report demonstrating that PMN-induced changes in epithelial biology occur at both early and later stages of the transepithelial migration process. Early events, defined as those that occurred before PMN entering the paracellular space, included enhanced epithelial permeability, increased phosphorylation of MLC at the actomyosin ring, and other proteins at the TJ. Later events occurring as PMN migrate through the paracellular space were characterized by the relocalization of phosphoserine proteins from the cytoplasm to the nucleus in epithelial cells directly adjacent to migrating PMN. These findings are discussed in the context of the regulation of PMN transepithelial migration during physiological and pathophysiological processes.
| Materials and Methods |
|---|
|
|
|---|
All Abs used in this study are listed in Table I
.
|
Stock cultures of T84 epithelial cell monolayers were grown as
previously described (23). For PMN transmigration
experiments, T84 monolayers were grown on
0.33-cm2 permeable supports with pores of 5 or
0.4 µm in diameter (Costar, Cambridge, MA) as either standard or
inverted monolayers (Fig. 1
A)
as previously described (23, 24). Confluence and TJ
maturation were determined by monitoring the transepithelial electrical
resistance (TER) to passive ion flow and were used when resistances had
reached
800
· cm2, generally
15002000
· cm2,
610 days postseeding
(25).
|
Normal human PMN were isolated from noncoagulated citrated blood by Ficoll-Paque (Amersham Pharmacia Biotech, Uppsala, Sweden) density sedimentation as per the manufacturers instructions. PMN were suspended in modified HBSS (Sigma-Aldrich, St. Louis, MO) containing 0.4 g/L KCl, 0.06 g/L KH2PO4, 8 g/L NaCl, 0.048 g/L Na2HPO4, 0.01 g/L glucose, and 10 mM HEPES (pH 7.4) at 4°C. For all transmigration experiments, PMN were suspended in HBSS containing 0.185 g/L CaCl2 and 0.098 g/L MgSO4. For some transmigration assays that were further evaluated by immunofluorescence microscopy, PMN were loaded with the fluorochrome 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester (BCECF-AM; Molecular Probes, Eugene, OR) as per the manufacturers instructions.
PMN transepithelial migration
PMN transmigration experiments were performed with standard or
inverted T84 monolayers as previously described in detail
(23) (Fig. 1
A). Briefly, the upper reservoir
was filled with 150 µl of HBSS with or without Abs, or
10-6 M fMLP in HBSS followed by the addition of
PMN to the upper well (106 or 2 x
106 total PMN per inverted or standard
monolayers, respectively). Monolayers were then transferred to wells
containing HBSS or 10-6 M fMLP
(t = 0) and incubated for the indicated time at
37°C. PMN that had migrated through the monolayer and into the lower
reservoir, or PMN found within the monolayer and filter, were
quantified by assaying for myeloperoxidase (23).
Microscopy
After a defined period of PMN transepithelial migration, T84 monolayers were washed with ice-cold HBSS. Non- or semiadherent PMN were removed by gentle washing with care taken to avoid disturbing the filter or T84 monolayer. For immunofluorescence analysis, monolayers were fixed with 10% neutral buffered formalin (Sigma-Aldrich) for 10 min at room temperature followed by treatment with 4 mg/ml sodium borohydride for 30 min to 1 h at 4°C. Monolayers were then permeabilized with 0.2% saponin (Sigma-Aldrich) in 1% BSA. Samples were incubated with primary Abs overnight at 4°C and then probed with secondary Abs coupled with Alexa-488 (Molecular Probes), Alexa-568 (1:1000), or Cy5 (1:500) (Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 h at room temperature. Cells were stained with rhodamine-phalloidin (1:1000; Molecular Probes) to visualize F-actin, or propidium iodide (1 µg/ml; Molecular Probes) to visualize the nuclei. Stained monolayers were mounted in Slow Fade medium (Molecular Probes) and examined using a Zeiss 510 confocal microscope (Zeiss, Oberkochen, Germany).
For light microscopy, samples were fixed with 4% buffered glutaraldehyde, postfixed in 1% osmium tetraoxide, dehydrated, and embedded. Semithin (500 nm) sections were stained with toluidine blue and examined by light microscopy.
Western blot analysis
Urea-glycerol gel electrophoresis was conducted on monolayers to analyze myosin L chain phosphorylation as performed by Garcia et al. (26) and isa modified method of Persechini et al. (27) and Verin et al. (28). T84 cells were scraped off the filter into HBSS containing protease and phosphatase inhibitors (10 µl/ml protease inhibitor mixture; catalog no. P8340, Sigma-Aldrich), 0.2 mM PMSF, 1 mM sodium fluoride, and 1 mM sodium orthovanadate at 4°C. Protein was precipitated with trichoroacetic acid (10% v/v) and 10 mM DTT for 30 min at 4°C, followed by pelleting in a microcentrifuge. The protein pellet was then washed with acetone, air-dried, and suspended in urea sample buffer, in which 15 µl of sample buffer was used per protein pellet from a single 0.33-cm2 monolayer. Equal protein amounts were run out on a native protein gel, transferred to nitrocellulose, and then analyzed by Western blot. The nitrocellulose was blocked with 3% BSA and probed with anti-MLC Ab followed by HRP-conjugated secondary Ab (Jackson ImmunoResearch Laboratories) and ECL to visualize the bands (Amersham Pharmacia Biotech). Band intensity was quantitated using the Chemi Image 5500, software version 3.4C (Alpha Innotech, San Leandro, CA).
For general analysis of protein phosphorylation (tyrosine, serine, and
threonine), whole cell lysates of T84 monolayers were prepared
following interaction of PMN with T84 monolayers for the specified
amount of time. T84 monolayers were washed free of adherent PMN and
scraped into lysis buffer containing 8 M urea and 1% SDS followed by
boiling for 10 min. Samples were mixed with Laemmli sample buffer and
equal amounts of protein were separated on 420% SDS PAGE (Bio-Rad,
Chicago, IL). Proteins were transferred to nitrocellulose and probed
with anti-phosphoprotein Abs (listed in Table I
) diluted in 3%
BSA/TBS overnight at 4°C followed by HRP-conjugated secondary Ab
and ECL.
FITC-dextran and mannitol permeability assays
Permeability was assessed by determining the flux of FITC-dextran (m.w., 3000; Molecular Probes) or [14C]mannitol (ICN Pharmaceuticals, Costa Mesa, CA) across T84 monolayers by passive diffusion in the basolateral to apical direction across the paracellular space as previously described (29, 30). A Beckman LS6000SC (Beckman Coulter, Fullerton, CA) was used for liquid scintillation counting and a Cytofluor Fluorescence Multiplate Reader (Applied Biosystems, Foster City, CA) was used for measuring fluorescence intensity.
| Results |
|---|
|
|
|---|
The results of PMN transepithelial migration assays across T84
monolayers in the apical to basolateral direction and the
physiologically relevant basolateral to apical direction toward a
gradient of fMLP are shown in Fig. 1
. Independent of the direction of
PMN transepithelial migration, each sample is defined by the conditions
of the upper and lower reservoirs as upper reservoir/lower reservoir
(see Fig. 1
A). For example, a sample with PMN added to the
upper reservoir and fMLP added to the lower reservoir would be listed
as PMN/fMLP. As we have previously shown, robust PMN migration occurred
toward fMLP (PMN/fMLP) in both directions, with the majority of
migrating PMN found in the lower reservoir (Fig. 1
, B and
C, filled bars) and a small component of PMN remaining in
the monolayer and filter (Fig. 1
, B and C, open
bars). PMN transmigration in the apical to basolateral direction
induced a decrease in TER, a measure of paracellular permeability, to
30% of the baseline resistance after 60 min (PMN were added to the
monolayer at t = 0 h) and correlated with PMN
migration into the lower chamber (Fig. 1
B; compare PMN
migration with the change in TER). The addition of inhibitory
anti-
2 integrin Abs, CD11b/CD18, to the
upper reservoir completely blocked PMN migration in the apical to
basolateral direction and the corresponding decrease in TER, as we have
previously shown (20, 23). Furthermore, no decrease in TER
was observed when PMN were added to the upper reservoir without a
chemotactic gradient (PMN/medium) or when fMLP was added to the upper
reservoir together with PMN (PMN + fMLP/medium).
Strikingly, a distinctly different TER response was seen when PMN
migration in the basolateral to apical direction was inhibited by the
addition of anti-CD11b/CD18 Abs (Fig. 1
C). While PMN
migration in the basolateral to apical direction was inhibited 89% by
anti-CD11b/CD18 Abs, a decrease in TER occurred similar to that
observed for uninhibited migration in either direction (Fig. 1
, compare
B and C, PMN/fMLP). Thus, marked inhibition of
transepithelial migration in the basolateral to apical direction still
resulted in a decrease in TER similar to that of uninhibited controls.
These results suggest that PMN applied to the basolateral surface of
T84 monolayers in the presence of a chemotactic gradient cause an
increase in epithelial permeability that is independent of
transepithelial migration.
PMN-induced decrease in epithelial monolayer TER does not correlate with migration
While anti-CD11b/CD18 Abs inhibited the majority of PMN
transepithelial migration, a small amount of migration occurred in the
basolateral to apical direction. Thus, experiments were designed to
test whether a small number of migrating PMN could cause a large
decrease in TER (Fig. 2
). As shown for
both conditions, increasing concentrations of fMLP or PMN resulted in a
decrease in TER that correlated with increasing numbers of migrating
PMN (uninhibited migration). Yet, when anti-CD11b/CD18 Abs were
used to inhibit PMN migration, the decrease in TER was far greater than
samples with the same or significantly greater amounts of migrating
PMN. These results indicate that the decrease in TER does not correlate
with PMN migration in the basolateral to apical direction and suggest
that PMN stimulate a change in barrier function when applied to the
basolateral surface of epithelial monolayers in the presence of a
transepithelial chemotactic gradient.
|
46 h to fall to minimal
levels.
|
Based on the above results, we hypothesized that the observed
PMN-stimulated, migration-independent decrease in TER might be due to a
soluble factor released from activated PMN. However, as shown in Figs. 1
C and 3A, when fMLP was added to the same
reservoir that contained PMN at a concentration that strongly activates
PMN (1 µM), no decrease in TER occurred, as would be expected if fMLP
stimulated the release of a soluble factor. Furthermore, we observed no
change in TER in monolayers treated with supernatants from samples with
PMN-stimulated decreases in TER (PMN/fMLP, data not shown). The
addition of protease inhibitors to the upper reservoir did not inhibit
the drop in TER stimulated by PMN (data not shown), suggesting that the
decrease in epithelial TER was not due to PMN proteases. Also, the
addition of donor-matched serum (1% v/v) to the samples did not
inhibit the decrease in TER. Serum has been shown to inhibit PMN
-defensins (31) and elastase (32), two PMN
products shown to stimulate a decrease in epithelial barrier
function.
To test whether the TER response was dependent on cell-cell contact, we
placed an additional filter with 0.22-µm pores directly above the
filter on which the epithelial monolayer was cultured. This
configuration further separated PMN from epithelial cells by
1020
µm. This resulted in the ablation of the PMN-stimulated decrease in
TER, potentially due to the lack of direct physical contact between PMN
and epithelial cells.
We next processed samples for microscopic evaluation to determine
whether PMN were able to contact the T84 monolayer across the 0.4-µm
pore filters (Fig. 3
B). As can be seen, numerous cellular
processes are observed extending between adherent PMN and epithelial
cells on the opposite side of the surface. Samples of epithelial
monolayers cultured on filters for 7 days or PMN applied to filters
with fMLP in the lower chamber demonstrated that both cell types extend
cellular processes into the 0.4-µm pores (data not shown). These
images suggest that PMN and epithelial cells are able to contact each
other across 0.4-µm pore filters in the absence of transmigration and
that the observed permeability changes are due to contact-dependent
events.
Paracellular flux of small solutes is increased in PMN-stimulated monolayers
PMN-induced effects on epithelial barrier function were next
examined by measuring the unidirectional diffusion of
[14C]-D-mannitol and FITC-dextran
(3 kDa) across T84 monolayers cultured on 0.4-µm pore filters (Table II
). Pretreatment of T84 monolayers with
EDTA before the addition of
[14C]-D-mannitol or FITC-dextran to
disrupt TJ was used as a positive flux control. As demonstrated in
Table II
, PMN-stimulated T84 monolayers show enhanced permeability to
small solutes ([14C]-D-mannitol)
under conditions of inhibited transmigration. In addition, high-density
PMN transmigration in the basolateral to apical direction across
monolayers grown on 5-µm pore filters was used to evaluate enhanced
flux as a result of transmigrating PMN. For both positive controls, an
increase in [14C]-D-mannitol and
FITC-dextran flux was detected at 3 h and correlated with a
decrease in epithelial TER (Table II
). For samples in which PMN were
added to the basolateral aspect of T84 monolayers cultured on small
pore filters (0.4 µm), a migration-independent decrease in epithelial
TER correlated with enhanced flux of small solutes
([14C]-D-mannitol) but not larger
molecules (3-kDa FITC-dextran). PMN-induced mannitol flux across T84
monolayers cultured on 0.4- and 5-µm pore filters was not
significantly different at t = 3 h. While the flux
of FITC-dextran was slightly increased in 0.4-µm pore filters under
PMN/fMLP conditions, it was not significantly greater than that
observed for the negative controls.
|
Immunofluorescence microscopy experiments were performed to
evaluate the TJ and adherens junction (AJ) for structural alterations
secondary to PMN-stimulated changes in paracellular permeability. We
stained monolayers with PMN-stimulated, migration-independent decreased
TER for a comprehensive assortment of intercellular junction proteins,
including occludin, ZO-1, ZO-2, JAM, claudin-1, -2, or -5,
- and
-catenin, E-cadherin, and
-actinin (Fig. 4
, images shown only for occludin). As
shown in Fig. 4
, no alteration in occludin staining occurred for any
condition tested (Media/Media, PMN/Media, and PMN/fMLP). Similarly, no
changes in the staining profiles were observed for the other
intercellular junction proteins listed above (data not shown). These
results suggest that migration-independent changes in epithelial
barrier function are not secondary to gross alterations in
intercellular junctional structure.
|
|
Phosphorylation of the regulatory L chain of myosin II (MLC)
has been shown to induce enhanced paracellular permeability of both
epithelial (33, 34) and endothelial cells
(26). We examined T84 monolayers with PMN
migration-independent, stimulated enhanced permeability for changes in
MLC. An increase in localization of MLC at the actomyosin ring was
observed in PMN-stimulated samples (data not shown). Furthermore,
Fig. 6
A demonstrates enhanced
phosphorylation of junction-associated MLC (pMLC) in PMN-stimulated
samples. For these experiments, inverted monolayers cultured on
0.4-µm pore filters were interacted with PMN for 3 h at 37°C,
followed by fixation and colabeling with rhodamine-phalloidin to
visualize the actomyosin ring and an Ab that specifically recognizes
only the phosphorylated form of MLC (pMLC) (Fig. 6
A).
Confocal en face images were then taken at the level of the actomyosin
ring. A low level of pMLC was found at the actomyosin ring in medium
and PMN control monolayers (Fig. 6
A). In monolayers with
PMN-stimulated, decreased barrier function (PMN/fMLP), a significant
increase in staining intensity of pMLC is seen. These results indicate
that an enhanced association of pMLC with F-actin filaments accompanied
the observed decrease in barrier function.
|
We next analyzed epithelial monolayers for similar changes in MLC
phosphorylation under conditions of active PMN migration. Just as
observed in samples with blocked PMN transmigration (Fig. 6
A, PMN/fMLP), an increase in anti-pMLC staining was
seen at the cell-cell junction (Fig. 6
C). For these
experiments PMN were allowed to migrate across T84 monolayers cultured
on 5-µm pore filters in the basolateral to apical direction for 15
min. Samples were then fixed and stained with anti-pMLC Ab.
Medium-only and PMN-only control monolayers demonstrated a low level of
pMLC at the apical junction. Markedly enhanced phosphorylation of MLC
at the apical junction was clearly observed throughout monolayers with
actively migrating PMN (Fig. 6
C). Because increased
phosphorylation of MLC was also observed in T84 monolayers cultured on
0.4-µm pore filters with PMN-stimulated decrease in TER (Fig. 6
A), these results indicate that increased phosphorylation
of MLC occurs before the passage of migrating PMN through the
epithelium. However, we observed that the level of MLC
phosphorylation remained elevated throughout the monolayer, suggesting
that there is a global increase in MLC phosphorylation. Alternatively,
it is possible that an increase in MLC phosphorylation is observed in
areas without PMN present as a consequence of PMN that had previously
migrated through that area.
PMN-stimulated decrease in TER is accompanied by changes in epithelial protein phosphorylation at the level of the TJ
Previous studies have shown that changes in the phosphorylation
state of TJ structural proteins results in modulation of paracellular
permeability (35, 36). Therefore, monolayers with
PMN-stimulated, migration-independent enhanced permeability were
examined for changes in tyrosine phosphorylation at the level of the TJ
by confocal microscopy (Fig. 7
). In the
medium control sample (Fig. 7
A, Media/Media),
anti-phosphotyrosine staining was observed at a low level in the
cytoplasm and at the TJ. A slight increase in intensity of
phosphotyrosine staining was observed in both the cytoplasm and TJ in
the PMN control sample (Fig. 7
B, PMN/Media), yet a
significant increase in phosphotyrosine staining was observed in the
cytoplasm and TJ in samples with PMN-stimulated enhanced paracellular
permeability (Fig. 7
C, PMN/fMLP). To distinguish changes at
the TJ from those at the AJ, monolayers were also colabeled with
anti-E-cadherin and anti-phosphotyrosine Abs. Unlike the
enhanced tyrosine phosphorylation at the TJ observed in PMN-stimulated
monolayers (PMN/fMLP), no change in the intensity of phosphotyrosine
staining at the AJ was observed in PMN-stimulated monolayers compared
with control monolayers (data not shown). Furthermore, these
phosphorylation changes were distinct from those observed with MLC in
Fig. 6
, as MLC is phosphorylated only on serine and threonine residues.
These results indicate that PMN stimulate changes in tyrosine
phosphorylation specifically at the TJ and suggest that TJ
phosphorylation occurs as an early event in the epithelial response to
PMN transmigration.
|
|
Changes in the staining patterns of phosphoserine and
phosphothreonine were also examined during both filter-inhibited and
-uninhibited PMN transmigration. As described in Fig. 8
, monolayers
were fixed and stained with Abs that specifically recognize
phosphoserine or phosphothreonine residues. No change in staining was
observed for phosphoserine staining in samples with filter-inhibited
PMN migration (data not shown). In addition, we did not consistently
observe significant alterations in phosphothreonine staining in T84
monolayers with filter-inhibited or noninhibited PMN migration.
However, dramatic alterations in the localization of phosphoserine
proteins were observed in samples with uninhibited PMN transmigration
(Fig. 9
). For these experiments,
BCECF-AM-loaded PMN were induced to migrate across T84 monolayers in
the basolateral to apical direction. After 5, 15, and 30 min of PMN
migration, the samples were fixed and stained with
anti-phosphoserine Ab and propidium iodide to visualize the nuclei.
While we did not see changes in serine phosphorylation at the TJ, a
significant redistribution of cytoplasmic phosphoserine staining into
the nucleus occurred (Fig. 9
, CE). After 5 min
of PMN transmigration, colocalization of phosphoserine proteins with
propidium iodide staining appeared to be throughout the
monolayer (Fig. 9
C). At later time points, 15 and 30 min
(Fig. 9
, D and E), colocalization of
phosphoserine proteins and propidium iodide appeared to be restricted
to the epithelial cells adjacent to transmigrating PMN. These results
suggest that transmigration of PMN activates signaling cascades that
result in relocalization of serine-phosphorylated proteins into the
nucleus within adjacent epithelial cells.
|
Given the immunofluorescence staining patterns of phosphoproteins
in
Figs. 79![]()
![]()
, we analyzed PMN-migrated monolayers by Western blot for
changes in phosphorylation of specific protein bands. As seen in Fig. 10
, changes in protein phosphorylation
levels (serine, threonine, and tyrosine) were observed for multiple
proteins. For these studies, whole cell lysates of T84 monolayers used
for PMN transmigration assays were separated by SDS-PAGE,
transferred to nitrocellulose, and probed with anti-phosphoserine-,
anti-phosphothreonine-, and anti-phosphotyrosine-specific Abs (Fig. 10
). Samples were run in triplicate and separately probed with the
three types of anti-phosphoprotein Abs. Actin was used as a protein
concentration loading control (data not shown). To control for
contaminating PMN proteins, equivalent numbers of PMN as would be
within such monolayers were analyzed in parallel. As can be seen in
Fig. 10
, several alterations in protein phosphorylation were observed
as either increases (Fig. 10
, arrows) or decreases (Fig. 10
, arrowheads) in band intensity or appearance/loss of bands from
monolayers with PMN transmigration as compared with control cell
lysates. An increase in phosphoserine and threonine staining intensity
was observed in a band at 20 kDa (Fig. 10
, large arrow). Reprobing
these Western blots with anti-MLC Ab confirmed that this protein
was MLC (data not shown), further supporting previous experiments
indicating that migrating PMN stimulate an increase in epithelial MLC
phosphorylation. An increase in phosphoserine staining of proteins at
28 and 30 kDa and an increase in phosphotyrosine staining of protein
bands at
10, 20, 30, and 35 kDa were also observed. Furthermore, a
decrease in phosphothreonine staining of two proteins of 12 and 26 kDa
was seen.
|
| Discussion |
|---|
|
|
|---|
These findings suggest a two-step model of early and late events for PMN-stimulated changes in intestinal epithelial function during transepithelial migration. Early events include an increase in paracellular permeability to small solutes after subepithelial PMN are stimulated with a transepithelial gradient of the chemoattractant, fMLP. This effect is dependent upon PMN-epithelial cell contact but does not require transepithelial migration. Furthermore, early signaling events included migration-independent phosphorylation of intercellular junction-associated MLC and protein tyrosine phosphorylation at the level of the TJ. These epithelial changes were also observed during active PMN transepithelial migration, confirming that they are early components of this dynamic process. Analysis of epithelial lysates from monolayers during active PMN transepithelial migration confirmed alteration in phosphorylation of multiple proteins. Late events included redistribution of serine-phosphorylated proteins from cytoplasmic pools to the nucleus in epithelial cells adjacent to migrating PMN. This observation suggests that later events in transepithelial migration may involve activation of epithelial nuclear transcription factors.
Substantial evidence has accumulated demonstrating that extravagating
PMN play an active role in the alteration of endothelial barrier
function. This is thought to result in facilitating the passage of PMN
through the vasculature or blood brain barrier (4). While
there are likely similarities between mechanisms of PMN-induced
alteration of endothelial barrier function and epithelial barrier
function observed in this work, our laboratory has previously shown
that there are considerable differences between the process of PMN
transendothelial migration and PMN transepithelial migration
(19). For instance, while selectins (L-, P-, and
E-selectins) play an important role in capturing and rolling PMN along
the vascular endothelium during the initial stages of PMN attachment,
they do not appear to play a role in PMN adhesion to epithelia
(20). Second, even though CD11b/CD18 is required for firm
adhesion of PMN to both epithelia and endothelia preceding migration
(23), the endothelial ligand, ICAM-1, does not appear to
be involved in PMN migration across intestinal epithelia
(37). In fact, the epithelial counter receptor(s) for
CD11b/CD18 are currently undefined. Despite the lack of evidence
linking ICAM-1 to PMN transepithelial migration, there is evidence that
ligation of endothelial ICAM-1 by migrating PMN results in activation
of endothelial signaling cascades. In particular, Ab cross-linking or
ligation by
2 integrin of migrating
lymphocytes in brain and vascular endothelium activates signaling
pathways involved in regulation of the actin cytoskeleton, including
intracellular calcium release (38, 39, 40) and activation of
p60src (41), Rho (42, 43), and protein kinase C (44). This results in
enhanced endothelial permeability and facilitation of transendothelial
passage of PMN from the vasculature into the tissues (42, 45). Therefore, while ICAM-1 does not appear to play this role
in intestinal epithelia, it is reasonable to assume that another
basolaterally expressed ligand may play a related role during PMN
transepithelial migration.
We have begun to investigate possible epithelial ligands involved in
PMN-stimulated epithelial signaling. Due to the polarized nature of the
response, such a ligand would be basolaterally expressed. The addition
of inhibitory Abs to candidate proteins, including CD29, CD61, CD47,
and CD44, had no effect on the PMN-stimulated decrease in TER in our
assays (data not shown). On the PMN side, it is likely that the ligand
is not CD11b/CD18 because anti-CD11b/CD18 Abs fail to inhibit the
permeability response. Interestingly, CD18-independent adhesive events
have been shown to play an important role in transepithelial migration
in the lung (46). Indeed, we have observed that
CD18-independent migration accounts for 510% of the total PMN
migration in the basolateral to apical direction through intestinal
epithelial monolayers (see Fig. 1
).
PMN-activated signaling pathways in both endothelium and epithelium (as demonstrated in this work) result in changes in barrier function due to modification of the actin cytoskeleton by phosphorylation of MLC (47). Others have reported that phosphorylation of MLC can result from the activation of two separate signaling cascades, by Rho-associated kinase through the calcium-independent Rho effector pathway (48), and by MLC kinase (MLCK), a calcium/calmodulin-dependent kinase (49). During transendothelial migration, it has been shown that PMN can stimulate phosphorylation of MLC after adhesion to endothelial cells (50), and pharmacological inhibition of endothelial MLCK has been shown to result in decreased PMN transmigration (50). In intestinal epithelial cells, activation of protein kinase C, a serine/threonine kinase, results in increased TER through phosphorylation and inactivation of MLCK and hence decreased phosphorylation of MLC (51). Attempts to inhibit the PMN-induced decrease in TER with phosphorylation inhibitors have been inconclusive (data not shown). We believe this was due to the inherent problems of working with this two-cell system because these experiments required that the inhibitors be washed out before addition of PMN to avoid direct effects on PMN. In addition, some inhibitors resulted in direct effects on TER independent of PMN.
We also observed PMN-stimulated changes in generalized tyrosine phosphorylation at the level of the TJ before transepithelial migration that correlated with increased permeability. This finding is consistent with other inhibitor-based studies that demonstrated enhanced protein tyrosine phosphorylation at the TJ correlates with alterations in permeability (52, 53). For example, increased tyrosine phosphorylation of ZO-1 has been shown to result in enhanced paracellular permeability (52). We are currently investigating PMN-stimulated changes in phosphorylation of TJ proteins.
During active transepithelial migration, we observed redistribution of
serine-phosphorylated proteins from cytoplasmic pools to the nucleus in
epithelial cells adjacent to migrating PMN. Because this effect was not
observed with inhibited PMN migration, it is clearly dependent on
paracellular passage of PMN and thus occurs subsequent to
phosphorylation of MLC and other TJ proteins. This translocation event
is suggestive of PMN stimulation of an epithelial nuclear transcription
factor(s). A potential candidate would be NF-
B. However, we have not
observed relocalization of NF-
B subunit p65 from the cytoplasm to
nucleus in epithelial cell during PMN transepithelial migration (data
not shown). Studies are under way to identify specific epithelial
proteins that are phosphorylated during PMN transepithelial migration.
Further characterization of such PMN-stimulated effects on epithelial
cells will improve our understanding of the role of migrating
leukocytes on epithelial function and may provide new ideas for
therapeutic manipulation of pathologic inflammation of mucosal
surfaces.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Heather A. Edens, Division of Gastrointestinal Pathology, Department of Pathology and Laboratory Medicine, Emory University, 615 Michael Street, Whitehead Building, Room 123D, Atlanta, GA 30322. E-mail address: hedens{at}emory.edu ![]()
3 Abbreviations used in this paper: TJ, tight junction; AJ, adherens junction; PMN, polymorphonuclear leukocyte; TER, transepithelial electrical resistance; BCECF-AM, 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester; MLC, myosin L chain; pMLC, phosphorylated MLC; MLCK, MLC kinase. ![]()
Received for publication February 12, 2002. Accepted for publication May 1, 2002.
| References |
|---|
|
|
|---|
directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83:724.
subunit dependent and independent regulation of intestinal epithelial tight junctions. J. Biol. Chem. 276:35571.